ACTELION Inactive Instrument
Company Actelion CBOE EUROPE EQUITIES
Equities
ATLN
CH0010532478
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - CHF | - |
|
| 2017 | Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake | RE |
| 2017 | Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 107,329,410 | 2,009,425 ( 1.872 %) | 4,654,225 ( 4.336 %) | 1.872 % |
Company contact information
Actelion Ltd.
Gewerbestrasse 16
4123, Allschwil
+
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +18.62% | 125B | |
| +13.81% | 108B | |
| -7.37% | 24.21B | |
| +2.07% | 22.78B | |
| -10.79% | 17.96B | |
| -41.74% | 16.43B | |
| -14.04% | 16.37B | |
| +1.99% | 13.58B | |
| +27.66% | 11.66B |
- Stock Market
- Equities
- ATLN Stock
- ATLN Stock
- Company Actelion
